Thalidomide and discoid lupus erythematosus: case series and review of literature
Background: The anti-inflammatory drug, thalidomide, is often administered off-label especially in dermatology patients with diseases refractory to different medications. The drug’s mechanism of action is not well understood but clinical evidence suggests an immunomodulatory function. Although this...
| Published in: | Drugs in Context |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2022-03-01
|
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/thalidomide-and-discoid-lupus-erythematosus-case-series-and-review-of-literature |